WASHINGTON--(BUSINESS WIRE)--The 14th annual BIO CEO & Investor Conference wrapped up in New York City yesterday amidst renewed optimism among investors and signs that FDA approvals may be on the rise in 2012, according to BIO Industry Analysis survey data. The event closed with a record number of one-on-one meetings, increased attendance and panel sessions on the latest investment and deal making trends. Hosted by the Biotechnology Industry Organization (BIO), the event drew more than 1,200 industry leaders and hosted more than 1,300 one-on-one meetings.
